Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
109.8 USD | -1.98% | -0.78% | -10.70% |
May. 13 | US reclassification could drive fresh research funding into pot sector | RE |
May. 07 | Jazz Pharmaceuticals Insider Sold Shares Worth $548,250, According to a Recent SEC Filing | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.70% | 7.06B | |
+31.37% | 588B | |
-3.34% | 364B | |
+19.13% | 326B | |
+5.19% | 285B | |
+15.13% | 239B | |
+10.06% | 210B | |
-7.03% | 200B | |
+9.74% | 167B | |
-0.51% | 161B |
- Stock Market
- Equities
- JAZZ Stock
- News Jazz Pharmaceuticals plc
- Transcript : Jazz Pharmaceuticals plc Presents at Citi 18th Annual BioPharma Conference, Sep-07-2023 11